39. Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, Baum J, Singer S, Jolesz FA (2001) MR imaging-guided focused ultrasound sur- gery of fibroadenomas in the breast: a feasibility study. Radiology 219:176–185 40. Huber PE, Jenne JW, Rastert R, Simiantonakonis I, Sinn H, Strittmatter H, von Fournier D, Wannenmacher MF, Debus J (2001) A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res 61:8441–9447 41. Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y (2003) MR imaging-guided focused US ablation of breast cancer: histopathologic assess- ment of effectiveness– initial experi- ence. Radiology 227:849–855 42. Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y (2003) MR imaging-guided focused ultrasound surgery of breast cancer: correlation of dynamic contrast-enhanced MRI with histopathological findings. Breast Can- cer Res Treat 82:93–101 43. Zippel DB, Papa MZ (2005) The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review. Breast Cancer 12:32–38 44. Khiat A, Gianfelice D, Amara M, Boulanger Y (2006) Influence of post- treatment delay on the evaluation of the response to focused ultrasound surgery of breast cancer by dynamic contrast enhanced MRI. Br J Radiol 79:308–314 45. Furusawa H, Namba K, Thomsen S, Akiyama F, Bendet A, Tanaka C, Yasuda Y, Nakahara H (2006) Magnetic reso- nance-guided focused ultrasound surgery of breast cancer: reliability and effec- tiveness. J Am Coll Surg 203:54–63 46. Gianfelice D, Khait A, Boulanger Y, Amara M, Beblidia A (2003) Feasibility of magnetic resonance imaging-guided fo- cused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. J Vasc Interv Radiol 14:1275–1282 47. Furusawa H, Namba K, Nakahara H, Tanaka C, Yasuda Y, Hirabara E, Imahariyama M, Komaki K (2007) The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer 14:55–58 48. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ (2000) Outcome at 8 years after breast-conserving surgery and ra- diation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668–1675 49. Singletary SE (2002) Surgical margins in patients with early-stage breast cancer treated with breast con- servation therapy. Am J Surg 184:383– 393 50. Tartter PI, Kaplan J, Bleiweiss I, Gajdos C, Kong A, Ahmed S, Zapetti D (2000) Lumpectomy margins, reexci- sion, and local recurrence of breast cancer. Am J Surg 179:81–85 51. Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455– 1461 52. Kunos C, Latson L, Overmoyer B, Silverman P, Shenk R, Kinsella T, Lyons J (2006) Breast conservation surgery achieving ≥2 mm tumour-free margins results in decreased local- regional recurrence rates. Breast J 12:28–36 53. Fornage BD, Sneige N, Ross MI, Mirza AN, Kuerer HM, Edeiken BS, Ames FC, Newman LA, Babiera GV, Singletary SE (2004) Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 231:215– 524 54. Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, Kuhn W, Schild HH (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485–492 55. Shiraishi A, Kurosaki Y, Maehara T, Suzuki M, Kurosumi M (2003) Exten- sion of ductal carcinoma in situ: histopathological association with MR imaging and mammography. Magn Reson Med Sci 31:2159–2163 56. Kim do Y, Moon WK, Cho N, Ko ES, Yang SK, Park JS, Kim SM, Park IA, Cha JH, Lee EH (2007) MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol 8:32–39 57. Schouten van der Velden AP, Boetes C, Bult P, Wobbes T (2006) The value of magnetic resonance imaging in diagnosis and size assess- ment of in situ and small invasive breast carcinoma. Am J Surg 192:172– 178 58. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R (2003) A randomized comparison of sentinel- node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553 1441 59. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, De Cicco C, Manfredi G, Fernández JR (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983–990 60. Vargas HI, Dooley WC, Gardner RA, Gonzalez KD, Heywang-Köbrunner SH, Fenn AJ (2003) Success of sentinel lymph node mapping after breast can- cer ablation with focused microwave phased array thermotherapy. Am J Surg 186:330–332 61. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P (1998) The senti- nel node in breast cancer–a multicentre validation study. N Engl J Med 339:941–946 62. Hu Z, Yang XY, Liu Y, Sankin GN, Pua EC, Morse MA, Lyerly HK, Clay TM, Zhong P (2007) Investigation of HIFU- induced anti-tumour immunity in a mu- rine tumour model. J Trans Med 5:34 63. Rome C, Couillaud F, Moonen CTW (2007) Gene expression and gene ther- apy imaging. Eur Radiol 17:305–19 64. Moonen CTW (2007) Spatio-temporal control of gene expression and cancer treatment using magnetic resonance imaging-guided focused ultrasound. Clin Cancer Res 13:3482–3489 65. Plathow C, Lohr F, Divkovic G, Rademaker G, Farhan N, Peschke P, Zuna I, Debus J, Claussen CD, Kauczor HU, Li CY, Jenne J, Huber P (2005) Focal gene induction in the liver of rats by a heat-inducible promoter using focused ultrasound hyperthermia. Inv Radiology 40:729–735 66. Allen TM (1997) Liposomes: opportu- nities in drug delivery. Drugs 54(suppl 4):8–14 67. Kong G, Braun RD, Dewhirst MW (2001) Characterization of the effect of hyperthermia on nanoparticle extrava- sation from tumour vasculature. Cancer Res 61:3021–3032 68. Dittmar KM, Xie J, Hunter F, Trimble C, Bur M, Frenkel V, Li KC (2005) Pulsed high-intensity focused ultra- sound enhances systemic administra- tion of naked DNA in squamous cell carcinoma model: initial experience. Radiology 235:541–546 69. Frenkel V, Etherington A, Greene M, Quijano J, Xie J, Hunter F, Dromi S, Li KCP (2006) Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumour model: investigation of poten- tial enhancement by pulsed-high inten- sity focused ultrasound exposure. Acad Radiol 13:469–479